🌟 Exciting News! 🌟 We are thrilled to announce that Summit Therapeutics has earned the prestigious Great Places to Work® certification! This achievement reflects our commitment to creating an environment where innovation, collaboration, and personal growth thrive. At Summit, we are not just building groundbreaking therapies—we're building a company culture where our people are empowered, inspired, and valued. A huge thank you to our incredible team who make Summit such a special place to work. Together, we’re helping to shape the future! #GreatPlaceToWork #SummitTherapeutics #SMMTNewEra #Teamwork #Innovation #CompanyCulture #EmployeeExperience #ProudMoment
Summit Therapeutics, Inc.
Biotechnology Research
Miami, Florida 44,354 followers
Summit Therapeutics’ mission is to resolve serious, unmet medical needs for the betterment of overall human health.
About us
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate. We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Miami, Florida, and we have additional offices in Menlo Park, California, and Oxford, UK.
- Website
-
https://www.smmttx.com/
External link for Summit Therapeutics, Inc.
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Miami, Florida
- Type
- Public Company
- Founded
- 2003
- Specialties
- Oncology, Clinical Trials, and Health Care
Locations
-
Primary
Get directions
601 Brickell Key Dr
Suite 1000
Miami, Florida 33131, US
-
Get directions
2882 Sand Hill Rd
Menlo Park, California 94025, US
-
Get directions
136a Eastern Avenue
Milton Park
Abingdon, Oxfordshire OX14 4SB, GB
Employees at Summit Therapeutics, Inc.
Updates
-
As we celebrate #HispanicHeritageMonth throughout September, we honor the rich cultures, histories, and lasting contributions of Hispanic and Latinx communities in science, healthcare, and beyond. At #SummitTherapeutics, we believe that diversity drives innovation and compassion strengthens care. We’re committed to fostering equity in healthcare by ensuring our research, our teams, and our mission reflect the diverse world we serve. Together, we’re building a future where every voice is valued, and where representation leads to stronger, more inclusive breakthroughs for patients everywhere. That’s how we continue changing the future for the better, together. #SMMTNewEra #TeamSummit
-
On September 25, Summit joins the global community in recognizing #WorldLungDay, a day to raise awareness about the importance of lung health and to advocate for those living with respiratory diseases. Breathing is something many of us take for granted, until it’s compromised. Because behind every breath is a life full of strength, resilience, and potential. Summit remains committed to changing the future for the better, together. Learn more: https://www.smmttx.com/ #SMMTNewEra #TeamSummit #SummitTherapeutics
-
At #SummitTherapeutics, we are proud to be part of #WorldCancerResearchDay, working together to drive innovation grounded in compassion. Every study, every breakthrough, and every collaboration brings us closer to more targeted, effective treatments for the people who need them most. Because behind every discovery is a patient, a family, and a future worth fighting for. We’re committed to changing the future for the better, together. Learn more: https://www.smmttx.com #WCRD2025 #CancerResearch #ClinicalResearch #Oncology #LungCancer #NSCLC #SMMTNewEra #TeamSummit
-
Sunday, September 21, #SummitTherapeutics will be joining the GO2 for Lung Cancer San Francisco Bay Area 5K Run/Walk to stand alongside patients, survivors, and their loved ones. This event is an opportunity to connect directly with the lung cancer community, raise awareness, and show our unwavering support. Join us if you’re in the Bay Area: Click “Join Our Team” in the link below and complete your registration. Not local? You can still support GO2 for Lung Cancer by making a monetary donation by clicking on the link below! To Join or Donate: Summit Therapeutics - Fundraising For GO2 for Lung Cancer https://lnkd.in/evqPT_eS Thank you to all our participants, supporters, and advocates! Let’s keep changing the future for the better, together. #GO2Foundation #LungCancer #SMMTNewEra #TeamSummit
-
On September 17, we stand with the global healthcare community to honor #WorldPatientSafetyDay and to champion safety from the very beginning of care. At #SummitTherapeutics, our commitment to safety is woven into every step of innovation. Behind every treatment is a life that matters. It’s this responsibility that drives us to keep changing the future for the better, together. Learn more: https://www.smmttx.com #WPSD2025 #PatientCentricity #PatientSafety #Oncology #Cancer #SMMTNewEra #TeamSummit
-
Summit Therapeutics, Inc. reposted this
We are proud to announce that Summit Therapeutics is listed as Number 18 on Fortune Best Workplaces in BioPharma™ for 2025 in the Small and Medium Companies category. To learn more (Fortune Best Workplaces in BioPharma™ 2025 | Great Place To Work®) https://lnkd.in/geDbFfdx #SMMTNewEra #TeamSummit #SummitTherapeutics
-
We are proud to announce that Summit Therapeutics is listed as Number 18 on Fortune Best Workplaces in BioPharma™ for 2025 in the Small and Medium Companies category. To learn more (Fortune Best Workplaces in BioPharma™ 2025 | Great Place To Work®) https://lnkd.in/geDbFfdx #SMMTNewEra #TeamSummit #SummitTherapeutics
-
Summit would like to thank everyone who visited our Summit WCLC 2025 booth and followed along with us on our social channels throughout #WCLC25! We are reminded that the opportunities to work together across our industry and sectors to make positive changes are endless. Your enthusiasm and support have made this event memorable. Your interest and feedback are invaluable as we work towards innovative solutions. We look forward to continuing our journey together in advancing cancer care. See you next year! #WCLC25 #SMMTNewEra #Ivonescimab #TeamSummit #CancerResearch #oncology
-
-
Two ivonescimab posters were highlighted at WCLC 2025: https://lnkd.in/euGQe4zP •P1.11.65: Ivonescimab versus Pembrolizumab for PD-L1-Positive NSCLC: A Subgroup Analysis of HARMONi-2 by Tumor PD-L1 Expression Level. Presenter: Dr. L. Wang. Click here to view the poster: https://lnkd.in/egFTAHFm •P1.11.83. Ivonescimab versus Pembrolizumab for PD-L1-Positive NSCLC: A Subgroup Analysis of HARMONi-2 by Tumor Histology. Presenter: Dr. A. Xiong. Click here to view the poster: https://lnkd.in/ePYZH-9B We look forward to seeing you in Barcelona, Spain at Summit’s Medical Affairs Booth No. 204! *Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). #SMMTNewEra, #WCLC25, #Ivonescimab, #lungcancer, #oncology